Sencan Acar| Innovative Research Award | Autoimmune Liver Diseases

Published on by Biotechnology Scientist

Innovative Research Award

Sencan Acar
Istanbul Florence Nightingale Hospital, Turkey

Sencan Acar
Affiliation Istanbul Florence Nightingale Hospital
Country Turkey
Scopus ID 57193702255
Documents 33
Citations 127
h-index 7
Subject Area Autoimmune Liver Diseases
Event Biotechnology Scientist Awards

Sencan Acar is a researcher affiliated with Istanbul Florence Nightingale Hospital in Turkey whose documented scholarly profile includes research in the area of autoimmune liver diseases. The available Scopus profile records 33 documents, 127 citations, and an h-index of 7. [1] These bibliometric indicators provide a quantitative basis for considering the researcher within an academic recognition framework focused on innovative research.

Abstract

Sencan Acar is affiliated with Istanbul Florence Nightingale Hospital, Turkey, and has a documented scholarly profile associated with autoimmune liver diseases. According to the supplied Scopus author information, the profile contains 33 documents, 127 citations, and an h-index of 7. [1] The research profile is considered in relation to the Innovative Research Award at the Biotechnology Scientist Awards, with emphasis on documented scholarly activity, research continuity, and contribution to a specialized biomedical research area.

Keywords

  • Sencan Acar
  • Innovative Research Award
  • Autoimmune Liver Diseases
  • Biotechnology Research
  • Biomedical Research
  • Clinical Research
  • Research Impact
  • Biotechnology Scientist Awards

Introduction

Research concerning autoimmune liver diseases occupies an important position within contemporary hepatology and biomedical science because these disorders involve complex interactions between immune regulation, inflammation, genetics, environmental factors, and hepatic function. Scholarly work in this area can contribute to improved understanding of disease mechanisms, diagnosis, clinical characterization, and therapeutic strategies.

Within this research landscape, Sencan Acar’s documented affiliation with Istanbul Florence Nightingale Hospital and subject-area association with autoimmune liver diseases establish a clinical and biomedical context for evaluating the research profile. The available bibliometric record indicates sustained scholarly output represented by 33 documents and measurable citation activity. [1]

Research Profile

The available author information identifies Sencan Acar with Scopus Author ID 57193702255. The profile records 33 documents, 127 citations, and an h-index of 7. [1] These indicators are commonly used as descriptive measures of scholarly publication activity and citation visibility, although bibliometric indicators should be interpreted alongside the quality, relevance, originality, and broader significance of individual research outputs.

Research Contributions

The supplied research information places Acar’s scholarly activity within autoimmune liver diseases, a specialized area connecting immunology, hepatology, pathology, and clinical medicine. Research in this field may address disease classification, immunological mechanisms, diagnostic assessment, clinical outcomes, and management strategies. The available bibliometric record provides evidence of an established publication record but does not, by itself, establish the specific novelty or clinical effect of individual studies. [1]

For an innovation-focused academic recognition, relevant contributions may therefore be assessed through the originality of research questions, methodological rigor, reproducibility, publication quality, interdisciplinary relevance, and the extent to which findings advance scientific understanding or practical biomedical applications.

Publications

The supplied Scopus profile records 33 documents associated with the researcher. [1] This document count indicates a body of indexed scholarly output. A complete publication-level assessment would require examination of individual article titles, journals, publication dates, citation distributions, authorship roles, study designs, and research findings.

Because the available input does not provide a complete publication bibliography or individual DOI records, specific article titles and DOI identifiers are not attributed here. This approach avoids assigning publications or identifiers to the researcher without direct bibliographic verification.

Research Impact

The reported citation count of 127 and h-index of 7 provide quantitative indicators of the visibility of Acar’s indexed scholarly work. [1] Citation-based measures can help describe how frequently published work has been referenced by subsequent research, but they should not be interpreted as a standalone measure of scientific quality, innovation, or societal impact.

In the context of autoimmune liver diseases, research impact may also be considered through contributions to clinical knowledge, diagnostic reasoning, understanding of disease mechanisms, treatment approaches, interdisciplinary collaboration, and the translation of research findings into healthcare practice. A comprehensive evaluation would combine bibliometric evidence with qualitative assessment of the underlying publications.

Award Suitability

Acar’s documented affiliation, subject-area specialization, publication record, citation activity, and h-index provide a factual basis for consideration for an Innovative Research Award. [1] The relevance of the profile to an innovation-focused award can be further evaluated through the originality and scientific significance of the research outputs, methodological contribution, interdisciplinary value, and evidence of influence on subsequent research or clinical practice.

The Biotechnology Scientist Awards provide a recognition context for researchers whose work contributes to scientific and technological advancement. In an award assessment, bibliometric information can serve as one component of the evaluation, while the substantive content and quality of the candidate’s research should remain central to the determination.

Conclusion

Sencan Acar’s academic profile reflects documented research activity associated with autoimmune liver diseases and an affiliation with Istanbul Florence Nightingale Hospital in Turkey. The supplied Scopus information reports 33 documents, 127 citations, and an h-index of 7. [1] These indicators establish a measurable scholarly record that can support consideration for the Innovative Research Award, subject to detailed evaluation of the originality, rigor, relevance, and impact of the underlying research.

References

  1. Elsevier. (n.d.). Scopus author details: Sencan Acar, Author ID 57193702255. Scopus.
    https://www.scopus.com/pages/authors/57193702255
  2. The challenge of cholecystectomy after successful choledocholithiasis extraction in elderly patients with comorbidities
    https://www.scopus.com/pages/authors/57193702255

JuHyun Bae | Cancer immunotherapy | Best Researcher Award

Published on by Biotechnology Scientist

Best Researcher Award

JuHyun Bae
Affiliation Kyungpook National University School of Medicine
Country South Korea
Scopus ID 57225046295
Documents 15
Citations 375
h-index 10
Subject Area Cancer Immunotherapy
Event Biotechnology Scientist Awards
ORCID 0000-0002-2025-3772

JuHyun Bae
Kyungpook National University School of Medicine

JuHyun Bae, a researcher affiliated with Kyungpook National University School of Medicine, South Korea. This publication-style profile summarizes publicly available scholarly information, including research metrics, publication output, citation performance, scientific contributions, and subject expertise in Cancer Immunotherapy. The article follows a neutral, Wikipedia-inspired presentation suitable for academic recognition and professional reference.[1]

Abstract

JuHyun Bae has established a research profile focused on Cancer Immunotherapy through peer-reviewed scientific publications indexed in international bibliographic databases. Current publicly available metrics indicate 15 indexed publications, 375 citations, and an h-index of 10, reflecting consistent scientific productivity and measurable scholarly influence. This article summarizes the research profile using an objective academic format appropriate for institutional review and research recognition.[1]

Keywords

Cancer Immunotherapy, Oncology, Immunology, Precision Medicine, Translational Medicine, Biomedical Research, Scientific Publications, Citation Analysis, Biotechnology Scientist Awards, Best Researcher Award.

Introduction

Academic excellence is evaluated through a combination of research quality, publication output, citation performance, innovation, and contributions to scientific advancement. Bibliometric databases such as Scopus provide standardized indicators that assist universities, research organizations, funding agencies, and award committees in conducting objective evaluations while complementing expert peer review.[2]

Research Profile

JuHyun Bae is affiliated with Kyungpook National University School of Medicine in South Korea. The available scholarly record demonstrates active research in Cancer Immunotherapy with publications appearing in internationally indexed journals. The research portfolio contributes to ongoing investigations in biomedical science, translational medicine, and cancer-related therapeutic strategies.[1]

Research Contributions

  • Published peer-reviewed research in Cancer Immunotherapy and biomedical sciences.
  • Supported advances in translational oncology research.
  • Contributed to internationally indexed scientific literature.
  • Participated in collaborative biomedical research activities.
  • Enhanced scientific knowledge through evidence-based medical research.

Publications

The researcher’s Scopus profile records 15 indexed publications. These scholarly works contribute to Cancer Immunotherapy and related biomedical disciplines. Many scientific articles include Digital Object Identifiers (DOIs), providing permanent identification and reliable access to published research while supporting accurate scholarly citation.[3]

  • Peer-reviewed journal publications indexed in Scopus.
  • Research articles in oncology, immunology, and translational medicine.

Research Impact

Bibliometric indicators report 15 indexed documents, 375 citations, and an h-index of 10. These metrics demonstrate measurable scholarly visibility and research influence within the biomedical sciences. Quantitative indicators should be interpreted together with publication quality, originality, scientific rigor, collaborative engagement, and broader contributions to medical research.[1]

Award Suitability

Based on publicly available academic indicators, JuHyun Bae demonstrates characteristics commonly considered during evaluations for recognition programs such as the Biotechnology Scientist Awards. Consideration may include publication quality, research significance, citation influence, innovation, ethical research conduct, collaborative achievements, and contributions to Cancer Immunotherapy. Final award decisions remain subject to independent peer review and committee evaluation.[2]

Conclusion

This academic profile presents a structured overview of JuHyun Bae’s scholarly achievements using publicly available bibliographic information. The article follows a neutral encyclopedia-style presentation that emphasizes research productivity, publication performance, scientific impact, and professional contributions, making it suitable for academic reference, institutional evaluation, and research recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: JuHyun Bae, Author ID 57225046295. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57225046295
  2. Systematic discovery of immunomodulatory plant-derived nanoparticles reveals RNA-mediated macrophage reprogramming.
    https://www.sciencedirect.com/science/article/pii/S2452199X26003701?via%3Dihub
  3. Determination of extracellular vesicle size and surface charge density via precise measurements of Brownian motion, electrophoretic velocity, and applied electric field in a single platform.
    https://www.sciencedirect.com/science/article/abs/pii/S0925400526001486?via%3Dihub

Sinem Ulusan | Immunotechnology | Women Researcher Award

Published on by Biotechnology Scientist

Dr. Sinem Ulusan | Immunotechnology | Women Researcher Award

Washington State University | United States

Dr. Sinem Ulusan is an emerging immunology researcher specializing in humoral immunity, systems serology, and infectious disease biology with a strong focus on SARS-CoV-2 and related viral pathogens. Her work integrates multiplexed immunoassays and translational research approaches to uncover antibody-mediated immune mechanisms and disease outcomes across diverse populations. She has contributed to impactful studies on coronavirus immunity, vaccine responses, and antiviral antibody functions. Her research outputs include peer-reviewed journal publications, high-impact collaborative manuscripts, and international conference presentations. She has received multiple prestigious research awards and actively contributes as a reviewer for leading scientific journals, reflecting her growing influence in immunology research.

                            Citation Metrics (Scopus)

140

120

100

80

60

40

20

 

Citations
118
Documents
10
h-index
6

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

 

Ayesha Saeed | Immunology | Editorial Board Member

Published on by Biotechnology Scientist

Dr. Ayesha Saeed | Immunology | Editorial Board Member

Public Health Officer at Foundation University Islamabad | Pakistan

Dr. Ayesha Saeed is an accomplished researcher in microbiology, probiotics, molecular biotechnology, and microbial genomics, with a proven record of scientific contributions reflected by 123 citations, 10 peer-reviewed documents, and an h-index of 5 on Scopus. Her research spans probiotic strain isolation, antimicrobial profiling, microbial genomics, biosafety, and host–microbe interactions, particularly focusing on bacteria isolated from human milk and fermented foods. Dr. Saeed has authored impactful publications on CRISPR-Cas systems, bacterial genome engineering, antimicrobial resistance patterns, microbial diversity, and immunomodulatory responses in human cell lines. She has demonstrated strong expertise in next-generation sequencing analysis, bacterial whole-genome sequencing, RNA-Seq analytics, computational drug design, phylogenetic interpretation, and bioinformatics-driven molecular characterization. Her work also highlights the therapeutic potential of microbial metabolites, probiotic biosurfactants, and beneficial strains such as Streptococcus lactarius, S. salivarius, and Lactobacillus crispatus. Her research collaborations have contributed to understanding the role of probiotics in immune modulation, chemokine regulation, and antimicrobial resistance patterns in clinical and community settings. She has published influential papers in international journals including Gene Reports, PLoS One, Cytokine, Bioactive Carbohydrates and Dietary Fibre, and BioMed Research International, strengthening her standing in microbial biotechnology. With extensive experience in microbiological, molecular, and computational techniques, as well as peer-review involvement for several reputable journals, Dr. Saeed demonstrates strong scientific leadership, editorial insight, and multidisciplinary expertise. Her consistent research output, analytical proficiency, and contributions to advancing probiotic biotechnology and microbial science make her highly suitable for the Editorial Board Member position.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

Fariq, A., & Saeed, A. (2016). Production and biomedical applications of probiotic biosurfactants. Current Microbiology. (Cited by: 60)

Malik, S. S., Saeed, A., Baig, M., Asif, N., Masood, N., & Yasmin, A. (2018). Anticarcinogenecity of microbiota and probiotics in breast cancer. International Journal of Food Properties. (Cited by: 53)

Saeed, A., Yasmin, A., Baig, M., Khan, K., Heyat, M. B. B., Akhtar, F., Batool, Z., & Ahmad, I. (2023). Isolation and characterization of Lactobacillus crispatus, Lactococcus lactis, and Carnobacterium divergens as potential probiotic bacteria from fermented black and green olives. BioMed Research International. (Cited by: 16)

Saeed, A., Ali, H., Yasmin, A., Baig, M., Ullah, A., Kazmi, A., Ahmed, M. A., & Hussain, S. (2023). Unveiling the antibiotic susceptibility and antimicrobial potential of bacteria from human breast milk of Pakistani women: An exploratory study. BioMed Research International. (Cited by: 12)

Saeed, A., Yasmin, A., Baig, M., Ahmed, M. A., & Farooqi, Z. R. (2023). Streptococcus lactarius MB622 and Streptococcus salivarius MB620 isolated from human milk reduce chemokine IL-8 production in response to TNF-α in Caco-2 cell line: An exploratory study. Cytokine. (Cited by: 11)